Treatment of multiple drug-resistant tuberculosis (MDR-TB) in Iran

被引:41
作者
Mirsaeidi, SM
Tabarsi, P
Khoshnood, K
Pooramiri, MV
Rowhani-Rahbar, A
Mansoori, SD
Masjedi, H
Zahirifard, S
Mohammadi, F
Farnia, P
Masjedi, MR
Velayati, AA
机构
[1] Iranian Natl Res Inst TB & Lung Dis, Dept TB & Resp Infect, Tehran 19556, Iran
[2] Yale Univ, Sch Publ Hlth, New Haven, CT USA
关键词
multiple drug-resistant; tuberculosis; treatment; Iran;
D O I
10.1016/j.ijid.2004.09.012
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Setting: Masih Daneshvari Hospital, Tehran, Iran, 2000-2002. Objective: To evaluate the effectiveness of multiple drug-resistant tuberculosis (MDR-TB) treatment for the first time in Iran. Design: All cases of MDR-TB with complete follow-up data were recruited and results of their treatments were evaluated. Results: MDR-TB treatment was initiated with 5.23 drugs, on average. Isoniazid, amikacin, and ofloxacin were present in the drug regimen of all patients. Average duration of the treatment was 18.5 months (range, 7-36). Over 76% of the patients responded to the treatment (negative smear and culture). Cure and probable cure were documented in seven (41.2%) and four (23.5%) of the patients, respectively. No failure in the treatment occurred when cycloserine was present in the treatment regimen. Conclusion: A majority of the MDR-TB patients in Iran can be cured with the use of appropriate treatment regimens. An even greater success could be achieved by providing more second-line drugs. (c) 2005 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:317 / 322
页数:6
相关论文
共 34 条
[11]   Outcome of multi-drug-resistant tuberculosis in France - A nationwide case-control study [J].
Flament-Saillour, M ;
Robert, J ;
Jarlier, V ;
Grosset, J .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 160 (02) :587-593
[12]  
Geerligs WA, 2000, INT J TUBERC LUNG D, V4, P758
[13]   TREATMENT OF 171 PATIENTS WITH PULMONARY TUBERCULOSIS RESISTANT TO ISONIAZID AND RIFAMPIN [J].
GOBLE, M ;
ISEMAN, MD ;
MADSEN, LA ;
WAITE, D ;
ACKERSON, L ;
HORSBURGH, CR .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (08) :527-532
[14]   Treatment of multidrug-resistant tuberculosis in Indonesia [J].
Hadiarto, M ;
Tjandra, YA ;
Hudoyo, A .
CHEMOTHERAPY, 1996, 42 :24-29
[15]  
HASS DW, 2000, PRINCIPLES PRACTICE, P2592
[16]   Management of multiple drug-resistant tuberculosis [J].
Hutchison, DCS ;
Drobniewski, FA ;
Milburn, HJ .
RESPIRATORY MEDICINE, 2003, 97 (01) :65-70
[17]  
Kim HJ, 2001, INT J TUBERC LUNG D, V5, P1129
[18]  
KUBICA GP, 1967, PUBLIC HLTH SERVICE, V1547
[19]   Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru. [J].
Mitnick, C ;
Bayona, J ;
Palacios, E ;
Shin, S ;
Furin, J ;
Alcantara, F ;
Sanchez, E ;
Sarria, M ;
Becerra, M ;
Fawzi, MCS ;
Kapiga, S ;
Neuberg, D ;
Maguire, JH ;
Kim, JY ;
Farmer, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (02) :119-128
[20]   Programmes and principles in treatment of multidrug-resistant tuberculosis [J].
Mukherjee, JS ;
Rich, ML ;
Socci, AR ;
Joseph, JK ;
Virú, FA ;
Shin, SS ;
Furin, JJ ;
Becerra, MC ;
Barry, DJ ;
Kim, JY ;
Bayona, J ;
Farmer, P ;
Fawzi, MCS ;
Seung, KJ .
LANCET, 2004, 363 (9407) :474-481